Company snapshot
- Ticker
- PHAR
- Exchange
- NGM
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $881.9M
- Employees
- 407
- Currency
- USD
- Website
- https://www.pharming.com
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral…
Latest coverage
- Pharming: 3 Key Takeaways for Long-Term Investors
November 4, 2026